• Users Online: 18997
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients

Anantharaman Giridhar, Ramkumar Gudapati, Gopalakrishnan Mahesh, Rajput Alpesh

Year : 2010| Volume: 58| Issue : 5 | Page no: 399-405

   This article has been cited by
 
1 How do polypoidal choroidal vasculopathy patients fare long term - A real world data
Sameer Iqbal, Manoj S, Asmita Indurkar, Ravi R V, Mancy Mathew, Unnikrishnan Nair
Indian Journal of Clinical and Experimental Ophthalmology. 2023; 9(1): 68
[Pubmed]  [Google Scholar] [DOI]
2 Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices
Yamini Sahu, Niharika Chaudhary, Mukesh Joshi, Aastha Gandhi
International Ophthalmology. 2021; 41(2): 753
[Pubmed]  [Google Scholar] [DOI]
3 Polypoidal choroidal vasculopathy: Pearls in diagnosis and management
Giridhar Anantharaman, Jay Sheth, Muna Bhende, Raja Narayanan, Sundaram Natarajan, Anand Rajendran, George Manayath, Parveen Sen, Rupak Biswas, Alay Banker, Charu Gupta
Indian Journal of Ophthalmology. 2018; 66(7): 896
[Pubmed]  [Google Scholar] [DOI]
4 Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
Prashant Jain, Giridhar Anantharaman, Mahesh Gopalakrishnan, Anubhav Goyal
Indian Journal of Ophthalmology. 2018; 66(8): 1119
[Pubmed]  [Google Scholar] [DOI]
5 ”Double-layer sign” on spectral domain optical coherence tomography in pachychoroid spectrum disease
Jay Sheth, Giridhar Anantharaman, Shruti Chandra, Sobha Sivaprasad
Indian Journal of Ophthalmology. 2018; 66(12): 1796
[Pubmed]  [Google Scholar] [DOI]
6 Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population
Parveen Sen, Muna Bhende, Ramya Sachidanandam, Nishat Bansal, Tarun Sharma
Indian Journal of Ophthalmology. 2016; 64(12): 908
[Pubmed]  [Google Scholar] [DOI]
7 Asian Age-Related Macular Degeneration
Laurence Shen Lim,,Chui Ming Gemmy Cheung,Tien Yin Wong
Asia-Pacific Journal of Ophthalmology. 2013; 2(1): 32
[Pubmed]  [Google Scholar] [DOI]
8 POLYPOIDAL CHOROIDAL VASCULOPATHY
Adrian H.C. Koh,Lee-Jen Chen,Shih-Jen Chen,Youxin Chen,Anantharam Giridhar,Tomohiro Iida,Hakyoung Kim,Timothy Yuk Yau Lai,Won Ki Lee,Xiaoxin Li,Tock Han Lim,Paisan Ruamviboonsuk,Tarun Sharma,Shibo Tang,Mitsuko Yuzawa
Retina. 2013; 33(4): 686
[Pubmed]  [Google Scholar] [DOI]
9 An Update in Laser and Pharmaceutical Treatment for Polypoidal Choroidal Vasculopathy
Timothy Y.Y. Lai,Wai-Man Chan
Asia-Pacific Journal of Ophthalmology. 2012; 1(2): 97
[Pubmed]  [Google Scholar] [DOI]
10 Management of peripheral polypoidal choroidal vasculopathy with intravitreal bevacizumab and indocyanine green angiography-guided laser photocoagulation
Rishi, P., Das, A., Sarate, P., Rishi, E.
Indian Journal of Ophthalmology. 2012; 60(1): 60-63
[Pubmed]  [Google Scholar]
11 Leitlinien zur Behandlung der feuchten Makuladegeneration
Michael Stur
Spektrum der Augenheilkunde. 2011; 25(1): 51
[Pubmed]  [Google Scholar] [DOI]
12 Anti-vascular endothelial growth factor drugs in polypoidal choroidal vasculopathy
Chhablani, J.
Indian Journal of Ophthalmology. 2011; 59(3): 256-257
[Pubmed]  [Google Scholar]

 

Read this article